We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Nemluvio Galderma Australia Pty Ltd
Product name
Nemluvio
Sponsor
Accepted date
May-2024
Active ingredients
nemolizumab
Proposed indication
For the treatment of moderate-to-severe atopic dermatitis.
Application type
A (new medicine)
Publication date
May-2024